• Examples

  • Systemic lupus erythematosus: induced by hydralazine or procainamide treatment

  • "Lupoid hepatitits": cathartic sensitivity

  • Autoimmune hemolytic anemia: methyldopa

  • Thrombocytopenic purpura: quinidine

  • Agranulocytosis: number of different drugs

• Demonstrated antibodies to the drug or tissue constituents.

• Idiopathic thrombocytopenic purpura: immune mechanisms

  • Granulocytes or blood platelets: damaged or activated by antigen-antibody complexes (may be destroyed by reticuloendothelial system)

• Drug-induced autoimmune reactions: usually result within several months, following drug withdrawal

• Immunosuppressive treatment required only if autoimmune response is unacceptably severe.

 Serum sickness and Vasculitic (Type III) Reactions

• More common then immediate anaphylactic reactions

• Clinical Characteristics:

  • Urticarial skin eruptions

  • Arthritis

  • Arthralgia

  • Lymphadenopathy

  • Fever

  • Duration: 6-12 days

  • Subsides after drug is discontinued

• Typically due to complement-fixing antibodies:IgM or IgG class

• Reduction of drug-induced serum sickness symptoms: corticosteroids

• Immune Vasculitis: may be drug-induced--(hypersensitivity angiitis)

  • Examples:

    • Sulfonamides

    • Penicillin

    • Thiouracil

    • Anticonvulsants

    • Iodides

  •  Mild skin disorder: erythema multiforme

    •   More severe reaction: Stevens-Johnson syndrome including:

      • Erythema multiforme

      • Arthritis

      • Myocarditis

      • Nephritis

      • CNS abnormalities

      • Associated with  sulfonamide administration

Haynes, B. F., Fauci, A.S. Disorders of the Immune System, In Harrison's Principles of Internal Medicine 14th edition, (Isselbacher, K.J., Braunwald, E., Wilson, J.D., Martin, J.B., Fauci, A.S. and Kasper, D.L., eds) McGraw-Hill, Inc (Health Professions Division), 1998, pp 1753-1776.

Carpenter, C. B. The Major Histocompatibility Gene Complex, In Harrison's Principles of Internal Medicine 14th edition, (Isselbacher, K.J., Braunwald, E., Wilson, J.D., Martin, J.B., Fauci, A.S. and Kasper, D.L., eds) McGraw-Hill, Inc (Health Professions Division), 1998, pp 1777-1782.

Cooper,M.D, and Lawton III, A. R. Primary Immune Deficiency Diseases, In Harrison's Principles of Internal Medicine 14th edition, (Isselbacher, K.J., Braunwald, E., Wilson, J.D., Martin, J.B., Fauci, A.S. and Kasper, D.L., eds) McGraw-Hill, Inc (Health Professions Division), 1998, pp 1783-1791

 

 

Disclaimer

This Web-based pharmacology and disease-based integrated teaching site is based on reference materials, that are believed reliable and consistent with standards accepted at the time of development. Possibility of human error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete. Users should confirm the information contained herein with other sources. This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site. Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals. Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.  Advertisements that appear on this site are not reviewed for content accuracy and it is the responsibility of users of this website to make individual assessments concerning this information.  Medical or other information  thus obtained should not be used as a substitute for consultation with practicing medical or scientific or other professionals.